Erratum to “Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients”

Erratum to “Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients”

Bibliographic Details
Main Authors:	Armando Calogero, Evangelista Sagnelli, Massimiliano Creta, Silvia Angeletti, Gaia Peluso, Paola Incollingo, Maria Candida, Gianluca Minieri, Nicola Carlomagno, Concetta Anna Dodaro, Massimo Ciccozzi, Caterina Sagnelli
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2019/8797329

Similar Items

Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients
by: Calogero Armando, et al.
Published: (2019-01-01)

Donor and Recipient Outcomes following Robotic-Assisted Laparoscopic Living Donor Nephrectomy: A Systematic Review
by: Massimiliano Creta, et al.
Published: (2019-01-01)

Familial polyposis coli: the management of desmoid tumor bleeding
by: Calogero Armando, et al.
Published: (2019-07-01)

Rituximab-Based Treatment, HCV Replication, and Hepatic Flares
by: Evangelista Sagnelli, et al.
Published: (2012-01-01)

Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: a meta-analysis on the role of response predictors.
by: Nicola Coppola, et al.
Published: (2014-01-01)

How Fear of COVID-19 Can Affect Treatment Choices for Anaplastic Large Cell Lymphomas ALK+ Therapy: A Case Report
by: Antonello Sica, et al.
Published: (2021-01-01)

An Anecdotal Case Report of Chronic Lymphatic Leukemia with del(11q) Treated with Ibrutinib: Artificial Nourishment and Physical Activity Program
by: Antonello Sica, et al.
Published: (2020-03-01)

Eradication of HCV in Renal Transplant Recipients and Its Effects on Quality of Life
by: Massimo Sabbatini, et al.
Published: (2018-01-01)

Letter to the editor: Successful eradication of HCV by short-course DAAs in HCV-Positive donor to HCV-Negative recipient during Haplo-HSCT
by: Yuh-Ching Gau, et al.
Published: (2020-11-01)

Treatment of chronic HBV infection in developing countries
by: Rosa Zampino, et al.
Published: (2016-11-01)

Transplantation of Renal Allografts From Organ Donors Reactive for HCV Antibodies to HCV-Negative Recipients: Safety and Clinical Outcome
by: Knut Michael Nowak, et al.
Published: (2017-01-01)

Gastroenterological complications in kidney transplant patients
by: Calogero Armando, et al.
Published: (2020-07-01)

Reply to letter to the editor: Successful eradication of HCV by short-course DAAs in HCV positive donor to HCV-Negative recipient during Haplo-HSCT
by: Chung-Feng Huang, et al.
Published: (2020-11-01)

Clinical Findings of HCV Chronic Infection in Undocumented Immigrants and Low-Income Refugees in Three Areas of Southern Italy
by: Evangelista Sagnelli, et al.
Published: (2018-01-01)

Primary Extra-Nodal DLBCL of Glands: Our Experiences outside Guidelines of Treatment
by: Antonello Sica, et al.
Published: (2021-03-01)

Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients.
by: Caterina Sagnelli, et al.
Published: (2017-01-01)

Outcomes of Renal Stone Surgery Performed Either as Predonation or Ex Vivo Bench Procedure in Renal Grafts from Living Donors: A Systematic Review
by: Nicola Longo, et al.
Published: (2020-01-01)

HBV/HDV Co-Infection: Epidemiological and Clinical Changes, Recent Knowledge and Future Challenges
by: Caterina Sagnelli, et al.
Published: (2021-02-01)

Colorectal cancer in the elderly patient: the role of neo-adjuvant therapy
by: Dodaro Concetta Anna, et al.
Published: (2019-08-01)

COVID-19 and Living Donor Kidney Transplantation in Naples during the Pandemic
by: Gaia Peluso, et al.
Published: (2020-01-01)

Does Physical Activity Regulate Prostate Carcinogenesis and Prostate Cancer Outcomes? A Narrative Review
by: Marco Capece, et al.
Published: (2020-02-01)

Efficacy of pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis
by: Coppola Nicola, et al.
Published: (2012-12-01)

Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
by: Mohamed Mohei El Badry, et al.
Published: (2020-11-01)

Successful eradication of genotype 4 HCV with telaprevir-based triple antiviral therapy
by: M.G. Deneke, et al.
Published: (2014-01-01)

Anemia in renal allograft recipients
by: V. A. Goryainov, et al.
Published: (2018-08-01)

Hypertension in Renal Allograft Recipients
by: Waiser Johannes, et al.
Published: (1999-01-01)

Epidemiology and management of hepatitis C virus infections in immigrant populations
by: Nicola Coppola, et al.
Published: (2019-03-01)

Tomoelastography for Longitudinal Monitoring of Viscoelasticity Changes in the Liver and in Renal Allografts after Direct-Acting Antiviral Treatment in 15 Kidney Transplant Recipients with Chronic HCV Infection
by: Stephan R. Marticorena Garcia, et al.
Published: (2021-02-01)

Hepatocellular carcinoma in patients without advanced fibrosis after eradication of HCV with antiviral treatment
by: Yolanda Sánchez-Torrijos, et al.

Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer
by: Nicola Carlomagno, et al.
Published: (2017-01-01)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals <sup>†</sup>
by: Silvia Molina-Carrión, et al.
Published: (2020-07-01)

A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients
by: Ulf Neumann, et al.
Published: (2012-01-01)

BACTERIAL INFECTIONS IN RECIPIENTS OF RENAL ALLOGRAFT
by: A. V. Vatazin, et al.
Published: (2012-09-01)

Chromoblastomycosis in a renal allograft recipient
by: Y S Sooraj, et al.
Published: (2013-01-01)

Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals
by: Tatsuya Minami, et al.
Published: (2021-06-01)

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents
by: Andrea Angeletti, et al.
Published: (2019-02-01)

Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients
by: Caterina Sagnelli, et al.
Published: (2014-03-01)

Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis.
by: Naoki Kawagishi, et al.
Published: (2018-01-01)

Allograft biopsies in management of pancreas transplant recipients.
by: Randhawa P
Published: (2002-01-01)

Urinary tract infection in the kidney allograft recipients
by: N K Rathnamalala
Published: (2012-01-01)